Effects of human corticotropin releasing factor (CRF) on gastric and pancreatic secretion in vivo and in vitro.
Human CRF given IV inhibited dose-dependently pentagastrin- but not histamine-induced gastric acid secretion. When added to the incubation medium of the isolated gastric glands, CRF did not alter the formation of HCl under basal conditions or after stimulation with histamine or DBcAMP. CRF caused a small but significant increase in pancreatic HCO3 and protein secretion. It augmented CCK-induced pancreatic protein and secretin-induced HCO3 secretion in vivo but failed to affect basal or stimulated (CCK and urecholine) amylase release by the in vitro dispersed pancreatic acini. This study indicates that CRF inhibits gastric and stimulates pancreatic secretion in vivo but not in vitro and these effects are indirect involving, at least in part, alterations in the pancreatic circulation.
D000818:Animals; D003346:Corticotropin-Releasing Hormone / Q000494:pharmacology*; D004285:Dogs; D005744:Gastric Acid / Q000502:physiology; D005753:Gastric Mucosa / Q000187:drug effects / Q000378:metabolism*; D005768:Gastrointestinal Hormones / Q000378:metabolism; D066298:In Vitro Techniques; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism*; D010418:Pentagastrin / Q000494:pharmacology; D011817:Rabbits
D005768:Gastrointestinal Hormones; D003346:Corticotropin-Releasing Hormone; D010418:Pentagastrin